Related by context. All words. (Click for frequent words.) 83 cycle modulating nucleoside 74 TELINTRA R 65 including eniluracil ADH 65 cytopenias due 65 sapropterin dihydrochloride Phase 64 Completes Patient Enrollment 63 AAG geldanamycin analog 63 generation purine nucleoside 63 mGluR5 negative 63 Meets Primary Endpoint 63 MKC# MT 63 SinuNase TM 63 Pivotal Phase 62 systemic lupus erythematosus rheumatoid 62 dependent kinase inhibitor 62 Initiated Phase 62 target enzyme purine 62 Completes Enrollment 62 Trial Evaluating 61 VEGFR2 inhibitor 61 lintuzumab SGN 61 Initiates Phase 61 CTAP# Injection 61 Commences Phase 61 alfimeprase direct 61 TKB# 61 recombinant PSMA vaccine 61 Initiates Phase II 61 Initiate Phase 61 oral nucleoside analogue 61 multicenter Phase III 61 nitric oxide donating prostaglandin 61 pharmacogenomic translational research 60 Phase 2b Clinical Trial 60 Receives Orphan Drug Designation 60 AstraZeneca PLC Arimidex 60 topical antifungal product 60 products MKC# PP 60 Successfully Completes Phase 60 Ovitrelle R Serostim 60 ® decitabine 60 PEG PAL PEGylated recombinant 60 Randomized Phase 60 Crofelemer budesonide foam 60 Pivotal Phase III 60 Investigational Oral 60 Telik logo TELINTRA 60 Luramist TM 60 Pivotal Study 59 Veronate R 59 Submits NDA 59 albiglutide 59 PRN FDA Approves 59 R roscovitine CDK cyclin 59 oral proteasome inhibitor 59 overactive bladder AA# 59 Zemiva ™ 59 Initiates Enrollment 59 Combination REOLYSIN R 59 XL# anticancer compounds 59 Pruvel TM 59 novel orally inhaled 59 candidates Azedra TM 59 6 sulfatase 59 Auxilium transmucosal film 59 phenylalanine ammonia lyase 59 Initiates Phase 2b 59 vapreotide acetate 59 clinical trials Archexin 59 Panzem R NCD 58 Rigel R# 58 approved incretin mimetic 58 sodium thiosulfate STS 58 Acetavance TM intravenous acetaminophen 58 JZP 58 ® bortezomib 58 MKC# 58 nucleoside phosphorylase PNP 58 Testosterone MDTS ® 58 signal detection CTSD 58 delivers fluocinolone acetonide FA 58 Phase IIb Trial 58 Phase IIb Clinical Trial 58 Phase IIa Clinical Trial 58 sapacitabine CYC# 58 CTA# Injection 58 Study Evaluating 58 Phase 2a clinical trials 58 orally inhaled migraine 58 Phase 2a Trial 58 Elagolix 58 Epothilone D 58 Nasdaq XTLB 58 Taro Receives 58 TRANSDUR ® 58 Forodesine 58 product platforms AZX# 58 modified glutathione analog 58 elderly myelodysplastic syndromes 58 includes TOLAMBA TM 58 TBC# 58 pan histone deacetylase 58 evaluating picoplatin 58 CB2 selective receptor agonist 58 generation DACH Platinum 58 Intermezzo ® zolpidem tartrate 58 Phase III Trials 57 mGluR5 NAM 57 PROVENGE ® 57 dimebon latrepirdine 57 palonosetron hydrochloride Injection Dacogen 57 KRYSTEXXA TM pegloticase 57 pralatrexate injection folate analogue 57 Receives Approvable Letter 57 Second Pivotal Phase 57 registrational trial 57 RECORD1 57 Frozen Shoulder syndrome Adhesive 57 NU# direct 57 Phase III Pivotal 57 QNEXA ® 57 Testosterone MDTS R 57 R MSCRAMM 57 Glufosfamide 57 LymphoStat B belimumab 57 XL# XL# XL# 57 Commence Phase 57 Vitrasert R 57 5 fluorouracil leucovorin 57 TRIOLEX HE# APOPTONE HE# 57 data management Clintrial 57 Initiates Clinical 57 Budesonide foam crofelemer 57 Phase III Clinical Trial 57 dacetuzumab SGN 57 Oral NKTR 57 candidate deforolimus 57 R ferumoxytol Injection 57 FUSILEV ® 57 R chorionic gonadotropin 57 seliciclib CYC# 57 Luveris R Ovidrel R 57 interferon beta 1a infertility 57 TMC# [002] 57 vomiting anorexia stomatitis 57 AN# topical anti 57 Parkinson disease levodopa induced 57 pentadentate logo R 57 EOquin TM phase 57 novel histone deacetylase 57 please visit www.abraxane.com 57 GVAX R 56 SPRYCEL ® 56 oral prodrug 56 rilonacept Injection 56 TRANSDUR ™ 56 Bayer HealthCare Onyx Pharmaceuticals 56 Announces Tentative Approval 56 Biopharmaceuticals AG 56 clinical trials SGN 56 dasatinib Sprycel ® 56 selective androgen receptor modulator 56 R sorafenib tablets 56 initiated Phase Ib 56 humanized therapeutic 56 Azedra TM 56 telomerase therapeutic 56 Wafer polifeprosan 56 Clinical Trial Evaluating 56 Vicriviroc 56 Dose Ranging Study 56 Transgenomic Pharmacogenomics Services 56 Achieves Primary Endpoint 56 leading oral taxane 56 Randomized Phase II 56 FOLOTYN ® 56 II Clinical Trial 56 Ophena TM 56 registrational Phase 56 Pivotal Trials 56 dihydrochloride Phase 3 56 selectin antagonist 56 Pruvel ™ prulifloxacin 56 Clinical Trial Results 56 oral picoplatin 56 liposomal formulation 56 development peramivir neuraminidase 56 BiTE R 56 Aflibercept 56 particularly SANCTURA XR 56 TLK# 56 ALN VSP Phase 56 refractory chronic lymphocytic 56 TO AVOID PREGNANCY WHILE 56 Mg Usa 56 BRIM2 56 Cytogen marketed 56 Phase 2a Clinical Trial 56 Ozarelix 56 R Saizen R 56 PATENT FOR 55 controlled multicenter Phase 55 Phase 2a Study 55 ILUVIEN ® 55 Zorbtive TM 55 developing Bicifadine serotonin 55 gemcitabine Gemzar ® 55 lead molecular radiotherapeutic 55 Phase IIb trials 55 sarcoma melanoma 55 Pivotal Trial 55 drug pipeline TAFA# 55 dextromethorphan quinidine 55 antiangiogenesis therapies 55 nasal calcitonin product 55 R bortezomib 55 Phase III multicenter 55 Cardium Therapeutics TM 55 TRACON Pharmaceuticals Inc. 55 Peyronie disease Frozen Shoulder 55 active AKT inhibitor 55 VISICOL R 55 trastuzumab DM1 T DM1 55 PDX pralatrexate 55 Phase III Clinical Trials 55 Atripla combines 55 systemic Phase 1b 55 BENLYSTA ® 55 ZYBRESTAT fosbretabulin 55 Matrix Phase 2b 55 generation URAT1 inhibitor 55 topical gel formulation 55 Trastuzumab DM1 55 progressive metastatic prostate 55 KSP inhibitor 55 ATRA IV 55 adecatumumab MT# 55 proprietary HuCNS SC 55 PANVAC VF 55 doxepin HCl 55 SPL# Gel vaginal microbicide 55 ENL recurrence 55 REPRONEX R menotropins 55 tumor activated prodrug 55 Civacir TM Hepatitis C 55 hypoxia activated prodrug 55 REVIVE Diabetes 55 SAR# [002] 55 Pharmos pipeline 55 alvespimycin 55 inflammatory PDE 55 ABL inhibitor 54 Phase 1b Clinical Trial 54 OMP #R# 54 TURNING INSIGHTS INTO HOPE 54 PREOS R 54 release capsules FENTORA 54 Phase 2b Trial 54 topically applied SEPA 54 oral taxane 54 unique alkylating agent 54 phase Ib 54 Pimavanserin 54 Provectus Pharmaceuticals specializes 54 Xeloda ® 54 % pramoxine HCl 54 systemic anaplastic large 54 RhuDex ® 54 Advancing Drugs 54 plus prednisone prednisolone 54 cyclobenzaprine hydrochloride extended 54 transthyretin mediated amyloidosis ATTR 54 transdermal estradiol gel 54 Phase Ib clinical trials 54 OvaRex R 54 Cloretazine ® 54 sorafenib tablets 54 armodafinil Tablets C 54 PrevOnco 54 TELCYTA R 54 Pruvel ™ 54 comparing alemtuzumab 54 Multiple Ascending Dose 54 Metastatic Melanoma 54 huN# DM1 54 compound INCB# 54 rALLy clinical trial 54 Linear ICs 54 First Patient Dosed 54 Aloprim TM allopurinol sodium 54 oncolytic virus therapies 54 PrevOnco ™ 54 Capsulitis 54 5 FU leucovorin 54 huC# DM4 54 CG# oncolytic virus 54 Sapacitabine 54 receptor tyrosine kinase inhibitor 54 Phase III Trial 54 syndrome overactive bladder 54 vinorelbine tartrate 54 Novolimus 54 Archexin 54 REVIVE TA 54 pseudomorphic high 54 ADVANCE ILLUMINATE 54 PEG IFN 54 fosbretabulin 54 mucositis ProLindac ™ 54 R rilonacept Injection 54 FDA APPROVES 54 R memantine HCl 54 R#/MEM # 54 Empatic ™ 54 recurrent metastatic ovarian cancer 54 blinded randomized placebo controlled 54 include Healive 54 ARRY # 54 dosing cohorts 54 infectious diseases autoimmune 54 Through Glycoscience 54 ferumoxytol Injection 54 GVT BMF & 54 advanced metastatic renal 54 cladribine Cladribine Tablets 54 GetGoal Phase III 54 Through Glycoscience R 54 Exherin TM 53 Ceflatonin R 53 lead Aganocide compound 53 TNFerade ™ 53 personalized cellular immunotherapy 53 LymphoStat B TM 53 biliary tract cancer 53 Phase 1b clinical trials 53 BENLYSTA ™ 53 omacetaxine mepesuccinate 53 evaluating mipomersen 53 memantine HCl 53 Phase III placebo controlled 53 Trofex TM 53 Confirmatory Phase 53 multicenter Phase 53 cathepsin K inhibitor 53 Plicera TM 53 induced mucositis 53 mitogen activated ERK kinase 53 myocardial infarction ventricular fibrillation 53 ® chorionic gonadotropin 53 Unigene nasal calcitonin 53 By DAN MORAN 53 GATTEX ® 53 Launches Generic Version 53 HDAC Inhibitor 53 treatment naïve genotype 53 Angiocept 53 REPRONEX ® menotropins 53 R DepoCyt 53 fentanyl citrate C 53 PDE4 inhibitor 53 HCV SPRINT 53 midstage clinical 53 APEX PD 53 Hydrochlorothiazide Tablets 53 JAK1 53 multicenter dose escalation 53 palifosfamide Zymafos TM 53 Neuvenge 53 PLEASE READ THE FOLLOWING 53 Tarceva TM 53 individualized cellular immunotherapy 53 ® DS methenamine 53 Staphylococcus aureus Immune Globulin 53 COMUNICADO DE 53 Phase 1a clinical 53 randomized controlled multicenter 53 granted Ortec 53 R roscovitine 53 toenail onychomycosis 53 SABER ™ 53 Bilive R combined 53 Enterobacter spp 53 Emergent marketed 53 FACTORS THAT CAN MATERIALLY 53 non personalized allogeneic 53 methylnaltrexone bromide 53 Alocrest 53 SUCCEED trial 53 AzaSite Plus 53 phenyl salicylate methylene blue 53 Phase III confirmatory 53 BRIM3 53 Copegus ® 53 Phase 2b Study 53 Novartis Trileptal 53 generation PNP inhibitor 53 ® ranolazine extended 53 Dose Escalation 53 milnacipran HCl 53 Fx #A 53 docetaxel Taxotere R 53 intranasal insulin product 53 NUVIGIL ® 53 investigational protease inhibitor 53 randomized controlled Phase 53 influenza BCX# purine nucleoside 53 Europe entitled MINDSET 53 Mg Uk 53 Vascular Wrap TM 52 somatropin Kuvan R 52 vascular occlusive diseases 52 Gel repository corticotropin injection 52 ongoing Phase 1b 52 FROM THE COMPANY 52 brentuximab vedotin SGN 52 Dementia Related Psychosis 52 dyskinesia PD LID 52 Zavesca r 52 Mylan Receives Approval 52 Phase IIIb 52 By CHRIS WOODKA 52 FREE ITUNES 52 assessing T DM1 52 Hematide ™ peginesatide 52 balsalazide disodium Capsules 52 ONLINE CHEAPEST DRUGS ONLINE 52 CDK cyclin dependent 52 Cetrorelix 52 IND enabling 52 IN DIAMETER 52 sodium sulfate sodium chloride 52 rALLy 52 PI3K/Akt pathway inhibitor 52 anti VEGF aptamer 52 including acne photodamage 52 R brand eszopiclone 52 bardoxolone 52 Trofex 52 ELADUR ™ 52 confirmatory pivotal 52 products Oncaspar ® 52 tumor angiogenesis inhibitors 52 Curis collaborator Genentech 52 INCHES WITH ISOLATED MAXIMUM 52 Phase Ib II 52 brand ciclesonide HFA 52 CHEAP ONLINE PHARMACY LOW 52 Proellex TM 52 PROCTOCORT R Suppository Hydrocortisone 52 azelastine hydrochloride 52 INSPIRE Trial Phase III 52 randomized #:#:# 52 urocortin 2 52 volociximab 52 PRICE FOR EXCELLENT 52 PSMA ADC 52 EGS# 52 COLAZAL R 52 AP Photo DCMC# 52 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 52 #-# rDNA origin 52 REG2 52 R SHOWTIME FAMILYZONE 52 METOZOLV ™ ODT metoclopramide 52 PRN4 52 Phase IIa trials 52 vaccines oncolytic virus 52 evaluating bafetinib 52 ONCONASE R 52 avanafil PDE5 inhibitor 52 Amgen Neulasta R 52 Amrubicin 52 R bisoprolol Euthyrox 52 evaluating Xcytrin 52 Multicenter Randomized 52 IIa clinical 52 tolevamer 52 CRLX# 52 TRC# 52 orally bioavailable 52 automated radiopharmaceutical distribution 52 drug conjugate 52 relapsed refractory multiple myeloma 52 R vancomycin hydrochloride 52 ACTIQ R oral transmucosal 52 KRN# 52 Pre RELAX AHF 52 next generation URAT1 52 Phase Ib IIa 52 trastuzumab DM1 52 OFFER FREE 52 dose escalation clinical 52 Nventa proprietary CoVal 52 investigational humanized monoclonal antibody 52 forodesine 52 Avise PG SM 52 HeartMate ® 52 Pharmacokinetic Study 52 Capesaris 52 Interferon alfa 2b 52 Randomized Controlled 52 DEB# 52 Phase Ib study 52 GRNVAC1 52 benzoic acid hyoscyamine sulfate 52 metastatic castrate resistant 52 AEG# 52 CysDisplay R 52 Aryplase 52 Atrisorb D R 52 CD#.# DOES NOT ENDORSE 52 GOUT 52 oral ridaforolimus 52 alfa 2a 52 NPC 1C 52 Avise MCV SM 52 HuCAL PLATINUM ® CysDisplay 52 Talotrexin 52 PRN1 52 pharmacokinetic PK study 52 CHEAP ONLINE PHARMACY BEST 52 double blinded placebo 52 SAR# [004] 52 Oral Suspension USP 52 Solution XOPENEX HFA 52 Hypoactive Sexual Desire Disorder 52 Annamycin 52 milnacipran HCI 52 mGluR5 antagonists 52 KARASH 52 successfully commercialize Iluvien 52 acute peptic ulcer 52 Allos Therapeutics Announces 52 overactive bladder VANTAS R 52 Protease Inhibitor 52 VICTOR E1 52 Numoisyn R 52 human agonistic monoclonal 52 immunosuppressive compound 52 NOX E# 52 AZX# Phase 52 KNS # 52 SET TO CONTINUE 52 R tiagabine hydrochloride NUVIGIL 52 Phase lll 52 Phase #b/#a clinical 51 APF# Phase 51 maximally tolerated dose 51 R Abelcet 51 PRICE GREAT DISCOUNT FREE 51 Additionally Soligenix 51 Daclizumab 51 markets COLAZAL 51 PF # [002] 51 metastatic ocular 51 Prodarsan ® 51 mertansine 51 initiate multicenter 51 oxacillin penicillin 51 cake Mah Karn 51 phenylketonuria PKU developed 51 romidepsin novel 51 Posiphen TM 51 Plicera 51 PROCTOCORT ® Suppository Hydrocortisone 51 PRN3 51 UltiMAb R technology 51 IMA# 51 Nasdaq MNKD focused 51 intravesical infusion therapy 51 markets HP Acthar 51 # pharyngula 51 commercialized DURECT 51 OSI Eyetech specializes 51 CCR5 mAb 51 NEBIDO VANTAS SUPPRELIN LA 51 Phase #/#a 51 LES EXPLOSIFS NORDEX LTEE 51 Retisert ® 51 3 registrational trial 51 mark eOn 51 NPSP# parathyroid hormone 51 GV# [001] 51 treats acute lymphoblastic 51 Nasdaq MNKD focuses 51 R metformin Concor 51 Dacogen injection 51 PRN2 51 please visit www.gnss.com 51 treatment naive genotype 51 EXPLORE Xa 51 NovaDel oral spray 51 Xcellerated T Cells 51 ON DEMAND TM 51 Viagra Soft Cialis Soft 51 tezampanel NGX# 51 YOUR LOCAL ANIMAL SHELTER 51 MAGE A3 ASCI 51 OW # 51 failure thrombosis embolism 51 CAREFULLY READ THESE MATERIALS 51 irinotecan doxorubicin oxaliplatin paclitaxel 51 Sodium Sulfate Sodium Chloride 51 IIa trial 51 hepatitis C protease inhibitor 51 metabolic disorders Saizen R 51 Amvisc Plus TM 51 dzikiyp @ gnnewspaper.com 51 PF # [001] 51 LUNESTA TM 51 label Lipofen R 51 WILL FEATURE 51 exploratory Phase IIa 51 분수대 51 THEY SAY THE 51 AP Photo SEL# 51 infection epistaxis dyspnea exfoliative 51 Nasdaq TGAL leading 51 anti CTLA 51 OctoPlus licensed 51 PEG PAL 51 PEG SN# 51 including cyclosporine methotrexate 51 PALIS PGAL ROSV SHOW 51 Phase #/#a trial 51 Tesetaxel 51 multicenter phase 51 opioid bowel dysfunction 51 VERSIONS OF 51 temsirolimus Torisel 51 RELOVAIR ™ 51 PAGE Staff Writer 51 Altera Nebulizer System 51 choriogonadotropin alfa injection 51 sapropterin dihydrochloride 51 oral chemotherapeutic agent 51 migraine headaches AZ 51 MAGAZINE 'S 51 Potassium Chloride Sodium Ascorbate 51 ODT metoclopramide HCl PEPCID 51 Marcus Gronholm BP 51 Pivotal Phase II 51 HEPLISAV ™ 51 OvaRex ® MAb 51 tramiprosate Alzhemed TM 51 systemic sclerosis SSc 51 dimer protein 51 NOTE POSIDUR ™ 51 phase IIa clinical 51 IMPACT IMmunotherapy 51 BY EDWARD CARIFIO 51 RESTORE CLI trial 51 mesylate tablets fluoroquinolone antibiotic 51 NASDAQ MNKD focuses 51 PEGylated interferon 51 BIIB# 51 NATIONAL ECONOMIC COUNCIL DIRECTOR 51 Sentient specializes 51 Includes KCI proprietary 51 Suppository Hydrocortisone Acetate Rectal 51 1T Flash 51 RICHELIEU Que 51 Phase IIb clinical trials 51 product TNFerade TM 51 Phase Ib Clinical Trial 50 cardiometabolic diseases Glucophage 50 By Neil Osterweil 50 Serostim ® 50 PC DAC Exendin 50 jmarquardt@stcloudtimes.com 50 BY JOHN ECKBERG 50 R famotidine 50 STEALTH C 50 lorvotuzumab mertansine 50 Unanimously Recommends Approval 50 COMIC REEL WRAP 50 LUMINATE pivotal clinical 50 ESPECIALLY SINCE 50 NasdaqGM SPPI commercial 50 Phase 2b clinical trials 50 PRT# 50 hGH CTP Phase 50 EOquin TM 50 nano particle tumor suppressor 50 R SHOWTIME BEYOND 50 multicenter randomized placebo controlled 50 Syncria albiglutide 50 PRN8 50 Phase #b/#a trial 50 MICRODUR TM 50 PGAL SHOW 50 product ProBiora3 50 STOP COMPLAINING AND 50 Inc. www.coopersurgical.com develops 50 phase IIb clinical 50 rhIGFBP 3 50 UCB Brussels Belgium 50 WHEN YOU WERE DOWN 50 ularitide 50 Adagen R 50 OLpur TM H2H 50 BY ERIC BRADLEY 50 antibody MAb 50 endoscopic autofluorescence imaging 50 Prodarsan 50 cetuximab multiple sclerosis 50 GALNS 50 By QianMian #-#-# 50 plus fludarabine 50 ritonavir boosted danoprevir 50 SHOWCASE SHOWTIME EXTREME 50 PSN# [002] 50 SAI EGF 50 Hematology Molecular Pathology 50 Janis Joplin soundalike respiratory 50 non nucleoside HCV 50 Hemispherx flagship products 50 EVENT BRIEFS REFLECTS 50 elotuzumab 50 D3 mvEnterprise mvBase Omnis 50 fatigue headache chills 50 placebo controlled Phase 50 subcutaneous Herceptin 50 YOU OUT THERE 50 Zybrestat 50 CRMD# 50 INTRODUCES NEW 50 By MARION WILHOITE 50 oral sapacitabine 50 AFFECT MICROSEMI 'S 50 sunitinib malate 50 Prostate AdenoCarcinoma Treatment 50 By MANON L. 50 LOCAL NEWSPAPER 50 VANTAS ® 50 TOWARD THE WEST 50 TRY TO GET 50 FBOVESPA 50 LEVADEX orally inhaled 50 including myalgia fever 50 Ofatumumab 50 metastatic hormone refractory 50 Alseres Cethrin 50 placebo controlled Phase III 50 PLK1 SNALP 50 intranasal vaccines derived 50 Zemplar Capsules 50 perifosine KRX 50 LPLD Hemophilia B 50 AQ4N 50 randomized discontinuation trial 50 Gene Expression RAGE 50 & BOVESPA ENGI 50 sNDA submission 50 dihydroergotamine mesylate DHE 50 BY JENNIFER MOONEY 50 BY STEPHANIE A. WILKEN 50 STRANGE de 50 Product candidate Serada 50 delivers preprogrammed intermittent 50 mastercard viagra pillsgeneric viagra 50 Size LT#/#R-# models 50 BUPHENYL ® sodium phenylbutyrate 50 Barr Receives Approval 50 candidiasis bacterial infection 50 Spectrum Pharmaceutical 50 CHAMPION PCI 50 IMPACT DCM 50 Epivir R 50 SPIRIT FIRST 50 prednisone CHOP 50 OXi# 50 HCl PEPCID ® famotidine 50 multicenter Phase II 50 JAK inhibitor 50 cannabinor 50 Purchase CIALIS Need 50 Multicenter Phase 50 Sphingomab TM 50 HepeX B TM 50 subtype selective NMDA receptor 50 THE PARTICIPANTS PROXY SOLICITOR 50 occlusion PAO 50 Oral Solution OSMOPREP 50 Tyrima 50 budesonide MMX Phase III 50 DermaVir Patch 50 ® ZEVALIN 50 Atridox R Atrisorb 50 Phenoptin 50 STRIKE PRICE COMPARES TO 50 metastatic sarcomas 50 COPEGUS R 50 phase IIb trial 50 decreased matrix metalloproteinase 50 THESE STATEMENTS FOR REVISIONS 50 STOCKS AROUND THE 50 IMC #B 50 compound AEZS 50 CRM# Protein 50 YOUR LAPTOP PRINTER DESKTOP 50 imetelstat GRN#L 50 LUVENIQ 50 counter brand ESOTERICA 50 By THERESA CAMPBELL 50 OR ESTIMATE 50 MAP# 50 Vitamin D analogue 50 Phase 2a trial 50 evaluating tesamorelin 50 By XiaoBing #-#-# 50 treat hyperproliferative disorders 50 BY WILLIAM ROLLER 50 DURECT proprietary 50 Essence Ultra LifePak 50 ENTERTAINMENT ANNOUNCES 50 RNA TM DAEMONLOGGER 50 AP Photo XAN# 50 ALSO CALLED 50 PROCTOCORT R 50 AP PhotoExpress Network 49 Medidur TM FA 49 fidaxomicin Phase 49 Anturol TM 49 small molecule vanilloid 49 Eze Breeze R 49 LibiGel testosterone gel 49 CHARGES AFTER 49 TAXUS ATLAS 49 Inc. www.sanuwave.com 49 BY JANETTE FOR 49 Phase 2b clinical 49 METOZOLV TM ODT metoclopramide 49 AP Photo WCAP# 49 Likewise Stockwire.com 49 MONSTERSTOX.COM Monsterstox.com 49 catheter occlusion CO 49 randypeterson@dmreg.com 49 Zenvia Phase III 49 tranquilizers diazepam 49 BY CHRIS McDANIEL 49 candidate brentuximab vedotin 49 THE COMPANY 'S STRATEGIES 49 advanced ceramic nanomaterial 49 WERE YOU SURPRISED 49 BY AUDRA DS 49 Abong gold 49 fidaxomicin Phase 3 49 ADVANCE PD 49 Therapy RecoveryRx TM 49 MOTHER WOULD 'VE SAID 49 INDUSTRY ASSESSMENTS 49 GOES GOLD 49 TomTom NAVIGATOR software 49 BR.# 49 deforolimus 49 Procardia XL 49 Gabapentin GR 49 forodesine purine nucleoside phosphorylase 49 BOTTOM OUT 49 BOVESPA PFRM3 49 Medarex logo 49 Qnexa TM 49 fostamatinib 49 Racivir 49 transmucosal delivery system 49 QNEXA 49 THOSE ANTICIPATED IN 49 erlotinib Tarceva R 49 ® SHOWTIME WOMEN 49 NSABP B 49 Biomerix Corporation 49 UNSURE OVER 49 DIURIL R 49 Dose Escalation Study 49 ARE PROVIDED ON 49 BY LIZ CAREY 49 DDP# 49 BCG refractory carcinoma 49 LIPOSONIX TM 49 OHR/AVR# 49 EXTRA ® STARBURST 49 multicentre randomized 49 phase IIa 49 DRAGON QUEST FINAL FANTASY 49 ¢ ÃÆ'à † â 49 Augment Injectable 49 cough nasopharyngeal pain 49 OmniVision logo 49 * HUMIDITY 49 Dyloject TM 49 confirmatory Phase III 49 injection USP ENDOMETRIN 49 EndoTAG TM -1 49 Tengion Neo Bladder Augment 49 dose cohorts 49 BY KYLE BURCH 49 ASML Novellus Systems 49 orally dosed 49 BrachySil TM 49 BY ROB WEILER 49 researches develops licenses 49 Aclidinium 49 Cream Hydrocortisone Cream USP 49 therapeutic monoclonal antibody 49 4G WCDMA HSPA 49 plus Copegus 49 development environments DoubleCheck 49 SHAREHOLDERS ARE STRONGLY ADVISED 49 X# XCLUSIVE Britney Visited 49 multicentre randomized double 49 Nasdaq HSKA sells 49 diet iced teas 49 Androxal TM 49 GUSTAFSON ON 49 Aplidin R 49 MoxDuo ® 49 PALIS PGAL SHOW 49 CHIEF POLITICAL REPORTER 49 Offering Pilates 49 OmniPixel R OmniPixel2 TM 49 TMC# C# 49 CAN PREVENT 49 BY MICHAEL PUFFER 49 EXPOSED SKIN 49 USP Tablets VISICOL ® 49 Genz # 49 INCB# [001] 49 IS CRUCIAL 49 Advaxis Phase 49 ATTRIBUTING UNDUE CERTAINTY OR 49 arsenic trioxide injection GABITRIL 49 B Anflu R 49 ascending dose 49 mtrax@starbeacon.com 49 Phase III ADT 49 JUST CLICK ON 49 controlled multicenter 49 BY KEVIN LITTEN 49 formulates propriety 49 OR REFLECT THE 49 phase IIb study 49 BY NOAH BIERMAN 49 CDAD Clostridium difficile 49 PRN5 49 Phase 1b 49 Vitaxin 49 RUNS IN J 49 fungal infections malaria tuberculosis 49 MANAGEMENT 'S CURRENT BELIEFS 49 BY RYAN ERNST 49 vidofludimus 49 OMS# 49 Phase 2a clinical 49 Phase IIa clinical trials 49 PROTECT AF 49 bapineuzumab AAB 49 weakness dizziness headache 49 IS HOPING TO 49 * Azixa 49 inhaled liposomal ciprofloxacin 49 ASCEND HF 49 RapMAT ® 49 'S ® DOLMIO 49 SENOMYX ANNOUNCES 49 Tarvacin Anti Cancer 49 BEMA Buprenorphine 49 ZACTIMA 49 REJECT ANY BID 49 ® famotidine 49 L BLP# 49 clinic automation LabPas 49 IIa clinical trials 49 phase IIIb 49 CATIE AD 49 Phase 49 R CableHome 49 unresectable Stage III 49 SNT MC# 49 sodium benzoate prescription 49 placebo controlled dose escalation 49 R#/MEM 49 Phase IIA 49 UNCERTAINTIES OR OTHER FACTORS 49 BEHALF OF EACH MSCI 49 Quinamed 49 Spiegelmer ® 49 develop HBV reactivation 49 Degarelix 49 AND ACTUAL RESULTS 49 Loceryl ® 49 Pharmacokinetic PK 49 deliver innovative biomedicines 48 eliglustat tartrate 48 unproven detoxification 48 ORAL Solo 48 PINNACLEDIGEST.COM S PAST PERFORMANCE 48 baminercept 48 BY DAVID KRECHEVSKY